Valsartan
73 NDCs across 16 manufacturers|69 Generic,4 Brand
Valsartan is used to treat diabetic nephropathies, heart failure, hypertension and left ventricular dysfunction, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Dec 23, 1996, and the first generic was approved Jun 26, 2014. FDA's Orange Book lists 71 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $148 million on Valsartan across 4.7 million claims for 1.2 million beneficiaries.
Valsartan is available as 73 NDCs from 16 manufacturers (69 generic, 4 brand), with NADAC prices from $0.08 to $12.67 per EA — the most expensive product costs about 155× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
73
69G / 4B
Manufacturers
16
competing in market
Price Spread
$0.08 – $12.67
per EA
7d Activity
avg -3.7% WoW · of 73 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Camber Pharmaceuticals Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Angiotensin 2 Receptor Blocker class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
16 manufacturers producing VALSARTAN(4 pricing outliers)
Frequently Asked Questions
What is Valsartan used to treat?
Valsartan is used to treat diabetic nephropathies, heart failure, hypertension and left ventricular dysfunction, per the National Library of Medicine's MED-RT classification.
When did Valsartan become available as a generic?
FDA approved the first generic Valsartan (ANDA) on Jun 26, 2014. The Orange Book currently lists 71 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Valsartan?
In 2024, Medicare Part D spent $148 million on Valsartan across 4.7 million claims for 1.2 million beneficiaries.
How many Valsartan products are on the market?
The Valsartan drug market contains 73 NDCs from 16 manufacturers — 69 generic and 4 brand products.
What is the price range for Valsartan?
NADAC reference prices for Valsartan range from $0.0820 to $12.6745 per EA — the most expensive product costs about 155× the cheapest.
Is generic Valsartan cheaper than brand?
The average generic NADAC for Valsartan is $0.1143 per EA, versus $9.9639 for brand-labeled products — brand versions average about 87× the generic price.
Which manufacturers make Valsartan?
16 manufacturers list Valsartan in NADAC. Ranked by number of NDCs, the largest are Camber Pharmaceuticals Inc. (8), Alembic Pharmaceuticals Inc. (8), Dr. Reddy's Laboratories Inc. (5), Solco Healthcare US LLC (5), Novartis Pharmaceuticals Corporation (4).
How has the price of Valsartan changed recently?
Over the past 7 days, 1 Valsartan NDC rose and 63 fell, with a market-wide average change of -3.7%.